6.11 IVACAFTOR Tablet; 150 mg; Kalydeco®; Vertex Pharmaceuticals (Australia) Pty Ltd. Purpose of Application

First Page		Document Content
Date: 2015-03-16 01:05:15 Ivacaftor Phenols Quinolones Cystic fibrosis Vertex Pharmaceuticals Clinical trial VX-809 Health Medicine Anilides		6.11 IVACAFTOR Tablet; 150 mg; Kalydeco®; Vertex Pharmaceuticals (Australia) Pty Ltd. Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Download Document from Source Website File Size: 54,64 KB Share Document on Facebook

	Media release as of April 17, 2015 Interim report of BB Biotech AG as of March 31, 2015 Biotech sector continues to outperform – strengthened balance sheets will sustain the industry’s solid growth DocID: 19rGr - View Document
	PDF Document DocID: 17l0S - View Document
	PDF Document DocID: 16dH7 - View Document
	3 NOVEMBER 2011 MEDIA RELEASE Groundbreaking Cystic Fibrosis Study Brings Researchers Closer to Finding a Cure A revolutionary new treatment for Cystic Fibrosis (CF) has been uncovered during a groundbreaking study invol DocID: 1585E - View Document
	Chapter Chat W I N T E R DocID: 14J5M - View Document